Back
Diamondback Energy Vs. Keros Therapeutics Industry Stock Comparison
Sell
25
FANG
Diamondback Energy
Last Price:
170.46
Seasonality Move:
9.98%
Buy
62
KROS
Keros Therapeutics
Last Price:
56.44
Seasonality Move:
54.08%
Sell
25
Diamondback Energy (FANG)
is a Sell
Is Diamondback Energy a Buy, Sell or Hold?
- The current Diamondback Energy [FANG] share price is $168.91. The Score for FANG is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
- FANG is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
62
Keros Therapeutics (KROS)
is a Buy
Is Keros Therapeutics a Buy, Sell or Hold?
- The current Keros Therapeutics [KROS] share price is $56.92. The Score for KROS is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
- KROS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
FANG Stock Price Chart
What is Diamondback Energy's stock price today?
-
The Diamondback Energy share price today is $168.91
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FANG is experiencing selling pressure, which indicates risk of future bearish movement.
KROS Stock Price Chart
What is Keros Therapeutics's stock price today?
-
The Keros Therapeutics share price today is $56.92
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KROS is experiencing selling pressure, which indicates risk of future bearish movement.
FANG Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -3.57 | Sell |
| Relative Strength Index (14 RSI): | 34.15 | Sell |
| Chaikin Money Flow: | -3432478 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (174.19 - 192.11) | Sell |
| Bollinger Bands (100): | (184.72 - 203.38) | Sell |
KROS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.17 | Buy |
| Relative Strength Index (14 RSI): | 64.2 | Buy |
| Chaikin Money Flow: | -162874 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (47.46 - 56.8) | Buy |
| Bollinger Bands (100): | (45.02 - 53.82) | Buy |
FANG Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 180.07 | Sell |
| 20-day SMA: | 180.27 | Sell |
| 50-day SMA: | 190.16 | Sell |
| 200-day SMA: | 185.03 | Sell |
| 8-day EMA: | 178.45 | Sell |
| 20-day EMA: | 181.22 | Sell |
| 50-day EMA: | 187.33 | Sell |
| 200-day EMA: | 183.85 | Sell |
KROS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 55.92 | Buy |
| 20-day SMA: | 53.86 | Buy |
| 50-day SMA: | 50.03 | Buy |
| 200-day SMA: | 52.7 | Buy |
| 8-day EMA: | 55.87 | Buy |
| 20-day EMA: | 53.93 | Buy |
| 50-day EMA: | 51.33 | Buy |
| 200-day EMA: | 49.85 | Buy |
Diamondback Energy Earnings Growth & FANG Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.59 per share, an increase next quarter of $0.50 per share, an increase this year of $0.55 per share, and an increase next year of $0.91 per share.
Keros Therapeutics Earnings Growth & KROS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.08 per share, an increase next quarter of $0.02 per share, an increase this year of $0.30 per share, and a decrease next year of $0.44 per share.
Diamondback Energy Technical Analysis
| Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Keros Therapeutics Technical Analysis
| Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||